Alloantigen-specific regulatory T cells generated with a chimeric antigen receptor.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Journal of Clinical Investigation

• Publication date

  2016-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1172/JCI82771PMID 26999600PMCID PMC4811124
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Discarded Human Thymus Is a Novel Source of Stable and Long‐Lived Therapeutic Regulatory T Cells

  2016cited by this paper
• Going viral: chimeric antigen receptor T‐cell therapy for hematological malignancies

  2015cited by this paper
• 4-1BB Costimulation Ameliorates T Cell Exhaustion Induced by Tonic Signaling of Chimeric Antigen Receptors

  2015cited by this paper
• Identification of Chimeric Antigen Receptors That Mediate Constitutive or Inducible Proliferation of T Cells

  2015cited by this paper
• Regulatory T Cells Require TCR Signaling for Their Suppressive Function

  2015cited by this paper
• Type 1 diabetes immunotherapy using polyclonal regulatory T cells

  2015cited by this paper
• Epigenetic analysis of regulatory T cells using multiplex bisulfite sequencing

  2015cited by this paper
• Adoptive cellular therapy: A race to the finish line

  2015cited by this paper
• Chimeric antigen receptor T cells for sustained remissions in leukemia.

  2014cited by this paper
• Suppression of murine colitis and its associated cancer by carcinoembryonic antigen-specific regulatory T cells.

  2014cited by this paper
• Signals and pathways controlling regulatory T cells

  2014cited by this paper
• Continuous T cell receptor signals maintain a functional regulatory T cell pool.

  2014cited by this paper
• Continuous requirement for the T cell receptor for regulatory T cell function

  2014cited by this paper
• Helios+ and Helios− Cells Coexist within the Natural FOXP3+ T Regulatory Cell Subset in Humans

  2013cited by this paper
• Adoptive transfer of umbilical cord blood-derived regulatory T cells and early viral reactivation.

  2013cited by this paper
• The basic principles of chimeric antigen receptor design.

  2013influential reference
• Clinical Grade Manufacturing of Human Alloantigen‐Reactive Regulatory T Cells for Use in Transplantation

  2013cited by this paper
• An obligate cell-intrinsic function for CD28 in Tregs.

  2013cited by this paper
• Role of HLA in Hematopoietic Stem Cell Transplantation

  2012cited by this paper
• CAR/FoxP3-engineered T regulatory cells target the CNS and suppress EAE upon intranasal delivery

  2012cited by this paper
• The Role of the PI3K Signaling Pathway in CD4+ T Cell Differentiation and Function

  2012cited by this paper
• Administration of CD4+CD25highCD127− Regulatory T Cells Preserves β-Cell Function in Type 1 Diabetes in Children

  2012cited by this paper
• Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics.

  2011cited by this paper
• Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation.

  2011cited by this paper
• Massive ex Vivo Expansion of Human Natural Regulatory T Cells (Tregs) with Minimal Loss of in Vivo Functional Activity

  2011cited by this paper
• Sustained suppression by Foxp3+ regulatory T cells is vital for infectious transplantation tolerance

  2011cited by this paper
• Human Regulatory T Cells with Alloantigen Specificity Are More Potent Inhibitors of Alloimmune Skin Graft Damage than Polyclonal Regulatory T Cells

  2011cited by this paper
• Engineered artificial antigen presenting cells facilitate direct and efficient expansion of tumor infiltrating lymphocytes

  2011cited by this paper
• Molecular Modeling and Affinity Determination of scFv Antibody: Proper Linker Peptide Enhances Its Activity

  2010cited by this paper
• The promise and potential pitfalls of chimeric antigen receptors.

  2009cited by this paper
• Loss of FOXP3 expression in natural human CD4+CD25+ regulatory T cells upon repetitive in vitro stimulation

  2009influential reference
• Regulating the regulators: costimulatory signals control the homeostasis and function of regulatory T cells

  2009cited by this paper
• First-in-man clinical results of the treatment of patients with graft versus host disease with human ex vivo expanded CD4+CD25+CD127- T regulatory cells.

  2009cited by this paper
• Adoptive cell therapy for the treatment of patients with metastatic melanoma.

  2009cited by this paper
• Redirecting human CD4+CD25+ regulatory T cells from the peripheral blood with pre-defined target specificity

  2009cited by this paper
• Curing CNS autoimmune disease with myelin‐reactive Foxp3+ Treg

  2009cited by this paper
• Amelioration of colitis by genetically engineered murine regulatory T cells redirected by antigen-specific chimeric receptor.

  2009cited by this paper
• Induction of antigen-specific regulatory T cells in wild-type mice: Visualization and targets of suppression

  2008cited by this paper
• Prevention of acute and chronic allograft rejection with CD4+CD25+Foxp3+ regulatory T lymphocytes

  2008cited by this paper
• Redirection of regulatory T cells with predetermined specificity for the treatment of experimental colitis in mice.

  2008cited by this paper
• Conferring indirect allospecificity on CD4+CD25+ Tregs by TCR gene transfer favors transplantation tolerance in mice.

  2008cited by this paper
• Generation of potent and stable human CD4+ T regulatory cells by activation-independent expression of FOXP3.

  2008cited by this paper
• In vitro-expanded donor alloantigen-specific CD4+CD25+ regulatory T cells promote experimental transplantation tolerance.

  2007cited by this paper
• Dendritic cell–expanded, islet-specific CD4+ CD25+ CD62L+ regulatory T cells restore normoglycemia in diabetic NOD mice

  2007cited by this paper
• Ex Vivo-Expanded CD4+CD25+ Immunoregulatory T Cells Prevent Graft-versus-Host-Disease by Inhibiting Activation/Differentiation of Pathogenic T Cells1

  2006cited by this paper
• Monospecific bivalent scFv-SH: effects of linker length and location of an engineered cysteine on production, antigen binding activity and free SH accessibility.

  2006cited by this paper
• Only the CD45RA+ subpopulation of CD4+CD25high T cells gives rise to homogeneous regulatory T-cell lines upon in vitro expansion.

  2006cited by this paper
• Specificity of CD4+CD25+ Regulatory T Cell Function in Alloimmunity1

  2006cited by this paper
• Ex Vivo-Expanded CD4 CD25 Immunoregulatory T Cells Prevent Graft-versus-Host-Disease by Inhibiting Activation/ Differentiation of Pathogenic T Cells

  2005cited by this paper
• Expansion of Functional Endogenous Antigen-Specific CD4+CD25+ Regulatory T Cells from Nonobese Diabetic Mice1

  2005cited by this paper
• In Vitro–expanded Antigen-specific Regulatory T Cells Suppress Autoimmune Diabetes

  2004cited by this paper
• Human T regulatory cells can use the perforin pathway to cause autologous target cell death.

  2004cited by this paper
• Induction of antigen-specific immunologic tolerance by in vivo and in vitro antigen-specific expansion of naturally arising Foxp3+CD25+CD4+ regulatory T cells.

  2004cited by this paper
• Measuring T-cell–mediated cytotoxicity using antibody to activated caspase 3

  2003cited by this paper
• Growth and expansion of human T regulatory type 1 cells are independent from TCR activation but require exogenous cytokines

  2002cited by this paper
• Pancreatic lymph node-derived CD4(+)CD25(+) Treg cells: highly potent regulators of diabetes that require TRANCE-RANK signals.

  2002cited by this paper
• Human Cd25+Cd4+ T Regulatory Cells Suppress Naive and Memory T Cell Proliferation and Can Be Expanded in Vitro without Loss of Function

  2001cited by this paper
• The relative frequencies of HLA-DRB1*01 alleles in the major US populations.

  2000cited by this paper
• CD4+CD25+ Immunoregulatory T Cells Suppress Polyclonal T Cell Activation In Vitro by Inhibiting Interleukin 2 Production

  1998influential reference
• Total body irradiation and acute graft-versus-host disease: the role of gastrointestinal damage and inflammatory cytokines.

  1997cited by this paper
• A novel strategy for generating monoclonal antibodies from single, isolated lymphocytes producing antibodies of defined specificities.

  1996cited by this paper
• An experimental model of idiopathic pneumonia syndrome after bone marrow transplantation: I. The roles of minor H antigens and endotoxin.

  1996cited by this paper
• Role of the mixed lymphocyte culture (MLC) reaction in marrow donor selection: matching for transplants from related haploidentical donors.

  1994cited by this paper

• Isolation of Pure Stable Human Treg Cells Based on Expression of GPA33

  2026cites this paper
• Emerging Cell-Based Therapies for Systemic Sclerosis: From Stem Cells to CAR-T Cells

  2026cites this paper
• Regulatory T cell therapy for Graft-versus-Host Disease

  2025cites this paper
• Regulatory T Cells and Nanomaterials: Dual Perspectives in Therapeutics and Immunomodulation

  2025cites this paper
• Gene editing of CD3 epsilon to redirect regulatory T cells for adoptive T cell transfer

  2025cites this paper
• Tolerogenic Therapies in Cardiac Transplantation

  2025cites this paper
• Novel BCR-Targeting Fusion Proteins for Antigen-Specific Depletion of Alloreactive B Cells in Antibody-Mediated Rejection

  2025cites this paper
• T-regulatory cells for the treatment of autoimmune diseases

  2025cites this paper
• CAR T-cell therapy in autoimmune diseases: a promising frontier on the horizon

  2025cites this paper
• Convergence of mRNA technology and chimeric antigen receptor therapy: targeted technology optimizing targeted therapy

  2025cites this paper
• Immunometabolism of Liver Xenotransplantation and Prospective Solutions

  2025cites this paper
• Crossroads between autoimmunity and cancer: Underlying mechanisms and clinical implications.

  2025cites this paper
• Chimeric Antigen Receptor (CAR) T-cell Therapy: Engineering Immune Cells To Treat Liver Diseases.

  2025cites this paper
• Chimerism and immunological tolerance in solid organ transplantation

  2025cites this paper
• Cellular therapies for the prevention and treatment of acute graft-versus-host disease.

  2025cites this paper
• Cellular Therapies in Transplantation – Regulatory T Cell Therapies and Virus Specific Therapies

  2025cites this paper
• Opportunities and challenges harnessing antigen-specific CD4+ regulatory T cells in inflammatory bowel disease

  2025cites this paper
• Regulatory T cell therapy for xenotransplantation, what perspectives?

  2025cites this paper
• Regenerative potential of immune cells after traumatic muscle injury

  2025cites this paper
• Lactic acid improves Treg manufacturing and in vivo function

  2025cites this paper
• CAR-T cell therapy: developments, challenges and expanded applications from cancer to autoimmunity

  2025cites this paper
• Generation of Human Chimeric Antigen Receptor Regulatory T Cells.

  2025cites this paper
• Permissive immunosuppression facilitates the expansion of ex vivo administered regulatory T cells in the lung allograft

  2025cites this paper
• 靶向调节性T细胞重塑外周免疫耐受：研究进展与未来方向

  2025cites this paper
• Breaking boundaries in ankylosing spondylitis: how innovative cell therapies reshape immunity, drive cutting-edge advances, and face future challenges

  2025cites this paper
• CAR-engineered cytolytic Tregs reverse pulmonary fibrosis and remodel the fibrotic niche with limited CRS

  2025cites this paper
• iPSC modification strategies to induce immune tolerance

  2025cites this paper
• CAR Treg synergy with anti-CD154 promotes infectious tolerance and dictates allogeneic heart transplant acceptance

  2025cites this paper
• Armored human CAR Treg cells with PD1 promoter-driven IL-10 have enhanced suppressive function

  2025cites this paper
• Cell therapy with human IL-10-producing ILC2s enhances islet function and inhibits allograft rejection.

  2025cites this paper
• CXCR5 engineered human and murine Tregs for targeted suppression in secondary and tertiary lymphoid organs

  2025cites this paper
• Chimeric anti-HLA antibody receptor engineered human regulatory T cells suppress alloantigen-specific B cells from pre-sensitized transplant recipients

  2025cites this paper
• Emerging CAR immunotherapies: broadening therapeutic horizons beyond cancer

  2025cites this paper
• Pretransplant targeting of TNFRSF25 and CD25 stimulates recipient Tregs in target tissues, ameliorating GVHD post-HSCT

  2025cites this paper
• From ex vivo to in vivo chimeric antigen T cells manufacturing: new horizons for CAR T-cell based therapy

  2025cites this paper
• Regulatory T Cell-Based Adoptive Cell Therapy in Autoimmunity

  2025cites this paper
• Inhibition of cell-mediated immunity in type 1 diabetes by beta cell-targeted PD-1 agonists in pancreas tissue slices

  2025cites this paper
• Enhancing Specific Thymic Treg Activation and Function with 4-1BB Monomeric Streptavidin-Based CARs.

  2025cites this paper
• From rough to refined: Applying diamond standards to CAR Treg development

  2025cites this paper
• Editorial: Repurposing cancer immunotherapies for use in autoimmunity and transplantation

  2025cites this paper
• Regulatory T cells in homeostasis and disease: molecular mechanisms and therapeutic potential

  2025cites this paper
• Advances in engineered T cell immunotherapy for autoimmune and other non-oncological diseases

  2025cites this paper
• Regulatory T cell approaches for graft-versus-host disease prevention.

  2025cites this paper
• Automated GMP-compatible production of universal CAR Tregs for organ-targeted tolerance induction

  2025cites this paper
• CAR Treg cells mediate linked suppression and infectious tolerance in islet transplantation in mice.

  2025cites this paper
• Why regulatory T cells love lactic acid

  2025influential citation
• Expanding the engineered Treg multiverse.

  2025cites this paper
• Chimeric Antigen Receptor Cells Solid Tumor Immunotherapy Assisted by Biomaterials Tools.

  2025cites this paper
• Engineered Regulatory T Lymphocytes Promote Infarcted Heart Repair.

  2025cites this paper
• Antigen-Specific Chimeric Antigen Receptor-T Regulatory Cells Home to Human Islets, Suppress Cytotoxic T Lymphocytes and Reverse Type 1 Diabetes.

  2025cites this paper
• Forkhead Box Protein P3 in the Immune System

  2025cites this paper
• Revolutionizing Allogeneic Graft Tolerance Through Chimeric Antigen Receptor-T Regulatory Cells

  2025cites this paper
• Synthetic receptor-based cell therapies for autoimmune diseases: an update.

  2025cites this paper
• Regulatory T cells in stroke inflammation: Therapeutic perspectives.

  2025cites this paper
• Selection and Characterisation of Minor Histocompatibility Antigen‐Specific Regulatory T Cells in Fully HLA‐Matched Setting for GVHD Therapy

  2025cites this paper
• Nanoneedle‐Based Electroporation for Efficient Manufacturing of Human Primary Chimeric Antigen Receptor Regulatory T‐Cells

  2025cites this paper
• HLA-A2 CAR/IL-2-CISC engineered Treg display robust in vitro and in vivo antigen-specific regulatory function

  2025cites this paper
• Chimeric anti-HLA antibody receptor engineered human regulatory T cells suppress alloantigen-specific B cells from pre-sensitized transplant recipients

  2025cites this paper
• Advances in Cell Replacement Therapies for Diabetes

  2025cites this paper
• CAR Tregs mediate linked suppression and infectious tolerance in islet transplantation

  2024cites this paper
• High affinity chimeric antigen receptor signaling induces an inflammatory program in human regulatory T cells

  2024cites this paper
• The enchanting canvas of CAR technology: Unveiling its wonders in non-neoplastic diseases.

  2024cites this paper
• Immune modulation in transplant medicine: a comprehensive review of cell therapy applications and future directions

  2024influential citation
• Genetic engineering of regulatory T cells for treatment of autoimmune disorders including type 1 diabetes

  2024cites this paper
• Application of chimeric antigen receptor therapy beyond oncology: A bibliometric and visualized analysis.

  2024cites this paper
• High-throughput CRISPR technology: a novel horizon for solid organ transplantation

  2024cites this paper
• Cellular Strategies for Separating GvHD from GvL in Haploidentical Transplantation

  2024cites this paper
• Harnessing regulatory T cells to establish immune tolerance

  2024cites this paper
• Dawn of CAR-T cell therapy in autoimmune diseases

  2024cites this paper
• Integration of ζ-deficient CARs into the CD3ζ gene conveys potent cytotoxicity in T and NK cells

  2024cites this paper
• Harnessing the biology of regulatory T cells to treat disease

  2024cites this paper
• T Cell Development and Responses in Human Immune System Mice.

  2024cites this paper
• Cell Therapy as a Way to Increase the Effectiveness of Hematopoietic Stem Cell Transplantation

  2024cites this paper
• High-affinity chimeric antigen receptor signaling induces an inflammatory program in human regulatory T cells

  2024cites this paper
• Chimeric antigen receptor T-cell therapy in autoimmune diseases

  2024cites this paper
• Cars pick up another passenger: Organ transplantation.

  2024cites this paper
• Quo vadis autoimmune hepatitis? - Summary of the 5th international autoimmune hepatitis group research workshop 2024

  2024cites this paper
• Pathophysiology and preclinical relevance of experimental graft-versus-host disease in humanized mice

  2024cites this paper
• From promise to practice: CAR T and Treg cell therapies in autoimmunity and other immune-mediated diseases

  2024cites this paper
• Combinatorial genetic engineering strategy for immune protection of stem cell-derived beta cells by chimeric antigen receptor regulatory T cells

  2024cites this paper
• Conferring alloantigen specificity to regulatory T cells: a comparative analysis of cell preparations undergoing clinical development in transplantation.

  2024cites this paper
• CAR immunotherapy in autoimmune diseases: promises and challenges.

  2024cites this paper
• Therapeutic potentials of adoptive cell therapy in immune-mediated neuropathy.

  2024cites this paper
• Regulatory cell therapy for kidney transplantation and autoimmune kidney diseases

  2024cites this paper
• Fourth generation CAR Tregs with PDCD1-driven IL-10 have enhanced suppressive function

  2024cites this paper
• Graft-Specific Regulatory T Cells for Long-Lasting, Local Tolerance Induction

  2024cites this paper
• CD39 delineates chimeric antigen receptor regulatory T cell subsets with distinct cytotoxic & regulatory functions against human islets

  2024cites this paper
• Regulatory T Cell Insufficiency in Autoimmune Diabetes Is Driven by Selective Loss of Neuropilin-1 on Intraislet Regulatory T Cells.

  2024cites this paper
• Human iPSC-derived CD4+ Treg-like cells engineered with chimeric antigen receptors control GvHD in a xenograft model.

  2024cites this paper
• Regulatory T cells: Genetic modifications and impact on disease treatment

  2024cites this paper
• IL23R-Specific CAR Tregs for the Treatment of Crohn’s Disease

  2024cites this paper
• Human OX40L–CAR-Tregs target activated antigen-presenting cells and control T cell alloreactivity

  2024cites this paper
• CAR Cells beyond Classical CAR T Cells: Functional Properties and Prospects of Application

  2024cites this paper
• The impact of regulatory T cells on the graft-versus-leukemia effect

  2024cites this paper
• Induction of FoxP3 Pre-mRNA Alternative Splicing to Enhance the Suppressive Activity of Regulatory T Cells from Amyotrophic Lateral Sclerosis Patients

  2024cites this paper
• Chimeric antigen receptor T cell therapy for autoimmune disease

  2024cites this paper
• Regulation of Treg cells by cytokine signaling and co-stimulatory molecules

  2024cites this paper
• Injectable Genetic Engineering Hydrogel for Promoting Spatial Tolerance of Transplanted Kidney in Situ

  2024cites this paper
• Chimeric antigen receptor Treg therapy in transplantation.

  2023cites this paper
• Promises and Pitfalls of Next-Generation Treg Adoptive Immunotherapy

  2023cites this paper